Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas-Reference-Cited by-同舟云学术

Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas

Published:2009-07-22 Issue:8 Volume:126 Page:1944-1954
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Chen Hua-Yun,Shao Cui-Jie,Chen Fu-Rong,Kwan Aij-Lie,Chen Zhong-Ping

Funder

National Natural Science Foundation of China

State Key Laboratory of Oncology in Southern China project 985-II

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. Malignant glioma: current treatment perspectives;Adams;J Neurosci Nurs,1991

2. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines;van de Vaart;Eur J Cancer,1998

3. Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future;Cavaliere;Expert Opin Pharmacother,2006

4. Peripheral blood leukocytes as a surrogate marker for cisplatin drug resistance: studies of adduct levels and the repair gene ERCC1;Parker;Basic Life Sci,1990

5. ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients;Dabholkar;J Natl Cancer Inst,1992

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance;Molecular and Cellular Biochemistry;2023-01-31

2. Perspectives of ERCC1 in early-stage and advanced cervical cancer: From experiments to clinical applications;Frontiers in Immunology;2023-01-11

3. Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A;Journal of Cell Communication and Signaling;2022-11-03

4. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance;Molecular Cancer;2022-07-18

5. DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?;Cancers;2022-06-13